Skip to content
PICO Portalanswers from OpenAlex

Outcome of patients with chronic limb-threatening ischemia with and without revascularization

PaperCitations, authors & open-access status

Outcome of patients with chronic limb-threatening ischemia with and without revascularization is a paper indexed in PICO Portal from OpenAlex.

How many citations does Outcome of patients with chronic limb-threatening ischemia with and without revascularization have?

PICO Portalcitation count

Outcome of patients with chronic limb-threatening ischemia with and without revascularization has 47 citations in the OpenAlex counts PICO Portal stores.

When was Outcome of patients with chronic limb-threatening ischemia with and without revascularization published?

PICO Portalyear

Outcome of patients with chronic limb-threatening ischemia with and without revascularization has 2019 year in the PICO Portal index.

What is the open-access status of Outcome of patients with chronic limb-threatening ischemia with and without revascularization?

PICO Portaloa status

Outcome of patients with chronic limb-threatening ischemia with and without revascularization has closed oa status in the PICO Portal index.

What is the DOI of Outcome of patients with chronic limb-threatening ischemia with and without revascularization?

PICO Portaldoi

The DOI for Outcome of patients with chronic limb-threatening ischemia with and without revascularization is on the source record.

What is the PMID of Outcome of patients with chronic limb-threatening ischemia with and without revascularization?

PICO Portalpmid

The PMID for Outcome of patients with chronic limb-threatening ischemia with and without revascularization is on the source record.

What is the OpenAlex record for Outcome of patients with chronic limb-threatening ischemia with and without revascularization?

PICO Portalopenalex

The OpenAlex for Outcome of patients with chronic limb-threatening ischemia with and without revascularization is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial